A senior source has provided information about a potential deal between AstraZeneca and Bristol Myers Squibb. According to this source, there are currently no discussions taking place between the two companies regarding a possible agreement. The source, who is close to the matter, has stated that no talks are ongoing.

This information was reported by Maggie Fick and Sabrina Valle. Further details about this situation can be found through Reuters, which initially reported the statement from the senior source.